217 related articles for article (PubMed ID: 34271120)
1. Caenorhabditis elegans as a model for studies on quinolinic acid-induced NMDAR-dependent glutamatergic disorders.
Limana da Silveira T; Lopes Machado M; Bicca Obetine Baptista F; Farina Gonçalves D; Duarte Hartmann D; Marafiga Cordeiro L; Franzen da Silva A; Lenz Dalla Corte C; Aschner M; Antunes Soares FA
Brain Res Bull; 2021 Oct; 175():90-98. PubMed ID: 34271120
[TBL] [Abstract][Full Text] [Related]
2. Quinolinic acid and glutamatergic neurodegeneration in Caenorhabditis elegans.
da Silveira TL; Zamberlan DC; Arantes LP; Machado ML; da Silva TC; Câmara DF; Santamaría A; Aschner M; Soares FAA
Neurotoxicology; 2018 Jul; 67():94-101. PubMed ID: 29702159
[TBL] [Abstract][Full Text] [Related]
3. Guanosine Prevents against Glutamatergic Excitotoxicity in C. elegans.
da Silveira TL; Machado ML; Arantes LP; Zamberlan DC; Cordeiro LM; Obetine FBB; da Silva AF; Tassi CL; Soares FAA
Neuroscience; 2019 Aug; 414():265-272. PubMed ID: 31306683
[TBL] [Abstract][Full Text] [Related]
4. Xenon acts by inhibition of non-N-methyl-D-aspartate receptor-mediated glutamatergic neurotransmission in Caenorhabditis elegans.
Nagele P; Metz LB; Crowder CM
Anesthesiology; 2005 Sep; 103(3):508-13. PubMed ID: 16129975
[TBL] [Abstract][Full Text] [Related]
5. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A
Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788
[TBL] [Abstract][Full Text] [Related]
6. Early modulation of the transcription factor Nrf2 in rodent striatal slices by quinolinic acid, a toxic metabolite of the kynurenine pathway.
Colín-González AL; Luna-López A; Königsberg M; Ali SF; Pedraza-Chaverrí J; Santamaría A
Neuroscience; 2014 Feb; 260():130-9. PubMed ID: 24361737
[TBL] [Abstract][Full Text] [Related]
7. [Hippocampus quinolinic acid modulates glutamate and NMDAR/mGluR1 in chronic unpredictable mild stress-induced depression].
Chen HB; Li F; Wu S; An SC
Sheng Li Xue Bao; 2013 Dec; 65(6):577-85. PubMed ID: 24343714
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the Toxic Effects of Quinolinic Acid and 3-Nitropropionic Acid in C. elegans: Involvement of the SKN-1 Pathway.
Kotlar I; Colonnello A; Aguilera-González MF; Avila DS; de Lima ME; García-Contreras R; Ortíz-Plata A; Soares FAA; Aschner M; Santamaría A
Neurotox Res; 2018 Feb; 33(2):259-267. PubMed ID: 28822104
[TBL] [Abstract][Full Text] [Related]
9. Toxic synergism between quinolinic acid and organic acids accumulating in glutaric acidemia type I and in disorders of propionate metabolism in rat brain synaptosomes: Relevance for metabolic acidemias.
Colín-González AL; Paz-Loyola AL; Serratos I; Seminotti B; Ribeiro CA; Leipnitz G; Souza DO; Wajner M; Santamaría A
Neuroscience; 2015 Nov; 308():64-74. PubMed ID: 26343296
[TBL] [Abstract][Full Text] [Related]
10. Reduced microglial immunoreactivity for endogenous NMDA receptor agonist quinolinic acid in the hippocampus of schizophrenia patients.
Gos T; Myint AM; Schiltz K; Meyer-Lotz G; Dobrowolny H; Busse S; Müller UJ; Mawrin C; Bernstein HG; Bogerts B; Steiner J
Brain Behav Immun; 2014 Oct; 41():59-64. PubMed ID: 24886967
[TBL] [Abstract][Full Text] [Related]
11. Quinolinic acid: an endogenous neurotoxin with multiple targets.
Lugo-Huitrón R; Ugalde Muñiz P; Pineda B; Pedraza-Chaverrí J; Ríos C; Pérez-de la Cruz V
Oxid Med Cell Longev; 2013; 2013():104024. PubMed ID: 24089628
[TBL] [Abstract][Full Text] [Related]
12. Dopamine modulation of avoidance behavior in Caenorhabditis elegans requires the NMDA receptor NMR-1.
Baidya M; Genovez M; Torres M; Chao MY
PLoS One; 2014; 9(8):e102958. PubMed ID: 25089710
[TBL] [Abstract][Full Text] [Related]
13. 3-Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum.
Guidetti P; Schwarcz R
Eur J Neurosci; 1999 Nov; 11(11):3857-63. PubMed ID: 10583474
[TBL] [Abstract][Full Text] [Related]
14. Characterization of striatal cultures with the effect of QUIN and NMDA.
Kumar U
Neurosci Res; 2004 May; 49(1):29-38. PubMed ID: 15099701
[TBL] [Abstract][Full Text] [Related]
15. Quinolinic acid stimulates luteinizing hormone secretion in female rats: evidence for involvement of N-methyl-D-aspartate-preferring receptors.
Johnson MD; Whetsell WO; Crowley WR
Exp Brain Res; 1985; 59(1):57-61. PubMed ID: 2990984
[TBL] [Abstract][Full Text] [Related]
16. Quinolinate potentiates the neurotoxicity of excitatory amino acids in hypoxic neuronal tissue in vitro.
Schurr A; Rigor BM
Brain Res; 1993 Jul; 617(1):76-80. PubMed ID: 8397046
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of the expression of NMDA receptors in human astrocytes.
Lee MC; Ting KK; Adams S; Brew BJ; Chung R; Guillemin GJ
PLoS One; 2010 Nov; 5(11):e14123. PubMed ID: 21152063
[TBL] [Abstract][Full Text] [Related]
18. Quinolinic acid stimulates somatostatin gene expression in cultured rat cortical neurons.
Patel SC; Papachristou DN; Patel YC
J Neurochem; 1991 Apr; 56(4):1286-91. PubMed ID: 1672145
[TBL] [Abstract][Full Text] [Related]
19. The 1993 Upjohn Award Lecture. Quinolinic acid induced brain neurotransmitter deficits: modulation by endogenous excitotoxin antagonists.
Jhamandas KH; Boegman RJ; Beninger RJ
Can J Physiol Pharmacol; 1994 Dec; 72(12):1473-82. PubMed ID: 7736338
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide synthase inhibition and glutamate binding in quinolinate-lesioned rat hippocampus.
Lisý V; Stastný F
Physiol Res; 2002; 51(3):299-307. PubMed ID: 12234123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
